Clinical Trial Update: A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Acetyl Hexapeptide-8 (AH8) for blepharospasm, a form of focal dystonia, has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Focal Dystonia

Drugs mentioned

• Acetyl Hexapeptide-8 (Acetyl Hexapeptide-8)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Focal Dystonia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-06